Jacob van Naarden, Chief Business Officer at Loxo Oncology, Inc. (LOXO), sold 695 shares at $89.23 ($62K) on 2018-01-17, disclosed to the SEC on 2018-01-18.
Open-market sale of $62k LOXO by Chief Business Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| LOXO | SELL | 2018-12-12 | $426K | — | Filing → |
| LOXO | SELL | 2018-12-12 | $120K | — | Filing → |
| LOXO | SELL | 2018-11-28 | $1.5M | — | Filing → |